Security key
514766104
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)
CUSIP: 514766104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 37,508,353
- Total 13F shares
- 24,334,820
- Share change
- -52,950
- Total reported value
- $179,104,999
- Price per share
- $7.36
- Number of holders
- 99
- Value change
- -$442,653
- Number of buys
- 46
- Number of sells
- 35
Report period
Q3 2025
Institutions
99
Top holders
10
LFCR full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
LIFECORE BIOMEDICAL, INC. \DE\ SEC filings
LIFECORE BIOMEDICAL, INC. \DE\ company facts
Broader feeds
Reporting periods
Holder history for CUSIP 514766104
Recent filing periods:
Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC |
13F
|
Company |
13%
|
4,703,216
|
$38,190,113 | — | 30 Jun 2025 | |
| Christopher S. Kiper |
3/4/5
|
Director, 10%+ Owner |
12%
|
4,481,329
|
$36,388,838 | — | 15 Jul 2025 | |
| Legion Partners Asset Management, LLC |
13F
|
Company |
12%
|
4,431,823
|
$35,986,403 | — | 30 Jun 2025 | |
| Greenhaven Road Investment Management, L.P. |
13F
13D/G
|
Company |
9.8%
from 13D/G
|
3,694,832
|
$30,002,036 | — | 30 Jun 2025 | |
| 22NW, LP |
13F
|
Company |
0.7%
|
264,180
|
$22,628,281 | — | 30 Jun 2025 | |
| 22NW Fund, LP |
13D/G
|
— |
7.5%
|
2,975,398
|
$20,768,278 | -$9,716,865 | 27 May 2025 | |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,703,216
|
$19,283,185 | — | 03 Oct 2024 | |
| 325 CAPITAL LLC |
13F
|
Company |
5.8%
|
2,162,466
|
$17,559,224 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5%
|
1,874,826
|
$15,223,587 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.3%
|
1,609,918
|
$13,072,535 | — | 30 Jun 2025 | |
| David Capital Partners, LLC |
13D/G
|
— |
4.9%
|
1,803,000
|
$11,467,080 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
775,493
|
$6,298,624 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
739,808
|
$6,007,244 | — | 30 Jun 2025 | |
| GRIZZLYROCK CAPITAL, LLC |
13F
|
Company |
2%
|
734,533
|
$5,964,408 | — | 30 Jun 2025 | |
| Paul Josephs |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,983,328
mixed-class rows
|
$5,186,956 | — | 08 Jul 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
531,041
|
$4,312,053 | — | 30 Jun 2025 | |
| DCF Advisers, LLC |
13F
|
Company |
1.2%
|
462,987
|
$3,759,454 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
379,413
|
$3,080,833 | — | 30 Jun 2025 | |
| James G. Hall |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
276,096
|
$2,876,920 | — | 01 Jun 2023 | |
| Ryan David Lake |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
936,691
mixed-class rows
|
$2,595,887 | — | 03 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.65%
|
243,395
|
$1,976,367 | — | 30 Jun 2025 | |
| Aron R. English |
3/4/5
|
10%+ Owner |
0.7%
|
264,180
|
$1,881,965 | -$9,132,503 | 23 May 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.54%
|
202,252
|
$1,642,286 | — | 30 Jun 2025 | |
| John D. Morberg |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
125,617
|
$1,308,929 | — | 18 Jan 2024 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.4%
|
151,700
|
$1,231,804 | — | 30 Jun 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.4%
|
148,190
|
$1,203,303 | — | 30 Jun 2025 | |
| Nelson Obus |
3/4/5
|
Director |
0.37%
|
138,193
|
$1,122,140 | — | 15 Jul 2025 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.36%
|
136,412
|
$1,107,666 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.33%
|
124,348
|
$1,010,000 | — | 30 Jun 2025 | |
| Craig A. Barbarosh |
3/4/5
|
Director |
—
class O/S missing
|
88,073
|
$917,721 | — | 08 Jul 2024 | |
| Katrina Houde Lovas |
3/4/5
|
Director |
0.29%
|
109,412
|
$888,436 | — | 15 Jul 2025 | |
| Joshua Schechter |
3/4/5
|
Director |
0.29%
|
107,173
|
$870,255 | — | 15 Jul 2025 | |
| Jeffrey L. Edwards |
3/4/5
|
Director |
—
class O/S missing
|
79,667
|
$830,130 | — | 08 Jul 2024 | |
| UBS Group AG |
13F
|
Company |
0.26%
|
96,651
|
$784,806 | — | 30 Jun 2025 | |
| Albert D. Bolles |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
72,883
|
$759,441 | — | 23 May 2022 | |
| Raymond H. Diradoorian |
3/4/5
|
Director |
—
class O/S missing
|
69,978
|
$729,171 | — | 08 Jul 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
87,690
|
$712,043 | — | 30 Jun 2025 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.23%
|
84,500
|
$686,140 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
83,076
|
$674,577 | — | 30 Jun 2025 | |
| Tonia L. Pankopf |
3/4/5
|
Director |
—
class O/S missing
|
59,599
|
$621,022 | — | 04 Jun 2022 | |
| Nathaniel Calloway |
3/4/5
|
Director |
—
class O/S missing
|
58,069
|
$605,079 | — | 08 Jul 2024 | |
| Catherine A. Sohn |
3/4/5
|
Director |
—
class O/S missing
|
54,069
|
$563,399 | — | 04 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
67,749
|
$550,122 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
61,800
|
$501,816 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.15%
|
55,677
|
$452,097 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
47,775
|
$387,933 | — | 30 Jun 2025 | |
| Humberto C. Antunes |
3/4/5
|
Director |
0.13%
|
47,060
|
$382,131 | — | 15 Jul 2025 | |
| Deborah D. Carosella |
3/4/5
|
Director |
—
class O/S missing
|
36,588
|
$381,247 | — | 04 Jun 2022 | |
| Diversified Trust Co |
13F
|
Company |
0.12%
|
46,062
|
$374,023 | — | 30 Jun 2025 | |
| Jason Aryeh |
3/4/5
|
Director |
0.12%
|
44,060
|
$357,771 | — | 15 Jul 2025 |
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2025
As of 30 Sep 2025,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,334,820 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., 325 CAPITAL LLC, BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GRIZZLYROCK CAPITAL, LLC, MORGAN STANLEY, and STATE STREET CORP.
This page lists
99
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
84
Q3 2025 holders
99
Holder diff
15
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.